SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst heightened competitive concerns following Amazon Pharmacy's direct offering of Novo Nordisk's GLP-1 weight loss pill, which many in the community view as a significant headwind. While a vocal bearish contingent cites overvaluation and predicts further downside, a segment of investors sees current price levels as a strong buying opportunity, banking on the company's diversified telehealth platform and international expansion. The market is actively debating HIMS's growth trajectory and valuation as it navigates this evolving competitive landscape.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals Inc. is witnessing extreme trading activity, primarily driven by a substantial special cash dividend and strong speculation of a short squeeze. The community is intensely focused on the company's evolving strategy to include blockchain-based assets and its leadership's track record of corporate turnarounds. This has ignited both fervent bullish sentiment and significant skepticism regarding the sustainability of its rapid price movement.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is a trending topic as significant share grants to CEO Michael Weiss have sparked intense debate among investors, leading to accusations of greed while also prompting discussions of potential short manipulation. The community remains focused on Briumvi's strong market performance, recent competitor setbacks, and high anticipation for strategic updates or acquisition speculation heading into the J.P. Morgan Healthcare Conference.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is currently trending due to a significant agreement with Meta Platforms to develop a nuclear energy campus in Ohio, aimed at powering future AI data centers. This deal, alongside anticipated DOE support for fuel and recent discussions on nuclear energy, has fueled intense bullish sentiment regarding the future of small modular reactors for AI infrastructure, despite some community concerns over current revenue and regulatory timelines.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending amid significant price volatility, as recent strong earnings were followed by a sharp decline, attributed by some to institutional profit-taking and an analyst downgrade. The community is actively discussing heightened competition in the observability sector, particularly from a rival's rumored acquisition, while also seeing the current levels as a compelling buying opportunity given Datadog's robust AI integrations and sticky revenue. Adding to the buzz, there are circulating rumors about Datadog itself exploring a potential takeover bid for GitLab.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint &amp; redeem rTokens.

StaFi

StaFi (FIS CRYPTO) is generating significant community excitement due to its recently announced token burn proposal, aiming for deflationary tokenomics, and a new roadmap for multi-chain and AI-powered liquid staking infrastructure. Despite a recent delisting, strong bullish sentiment persists, fueled by its perceived low market cap, continued presence on major exchanges, and anticipation of substantial upside as a liquid staking protocol.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is experiencing significant buzz following a substantial stock and warrant offering to an institutional investor, priced notably above recent trading levels. This move signals strong institutional confidence in the company's future growth, particularly within the burgeoning autonomous drone and defense technology sector. While some debate potential dilution, many in the community are bullish, anticipating major acquisitions and contracts, especially with an investor conference approaching and heightened global defense spending.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending following recent strategic financing that has extended its cash runway toward crucial Phase 3 myelofibrosis trial results anticipated in March 2026. This development, coupled with bullish options activity, sparks optimism, yet a significant portion of the community remains vocal about perceived management shortcomings, believing a leadership change would be the strongest catalyst for unlocking the drug's full potential within the oncology sector.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending intensely ahead of its imminent Q4 earnings report, amidst heated discussions surrounding the proposed acquisition of Warner Bros. Discovery and a recent price target adjustment. Community sentiment is sharply polarized, with bears emphasizing potential debt and regulatory hurdles, while bulls perceive current levels as a prime accumulation opportunity, anticipating a strong earnings performance.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending amid intense buyout speculation, fueled by strong financial performance and anticipation of critical updates on its AUR200 pipeline, particularly regarding planned Phase 2 indications. Community discussion highlights growing frustration with management's perceived lack of transparency, even as the company's strong fundamentals and recent patent lawsuit consolidation position it as a compelling acquisition target in a dynamic biotech M&A environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Down 8.3% in 4 Weeks, Here's Why GoDaddy (GDDY) Looks Ripe for a Turnaround 

The heavy selling pressure might have exhausted for GoDaddy (GDDY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

GoDaddy (NYSE:GDDY) Sets New 1-Year Low - Here's Why

GoDaddy (NYSE:GDDY) Hits New 1-Year Low - Here's What Happened...

Do you need a digital will for online accounts?

For decades, estate planning focused on homes, bank accounts and investments. Today, the list of assets that matter after death or incapacity has expanded to include email accounts, social media...

Railway Pension Investments Ltd Acquires 23,300 Shares of GoDaddy Inc. $GDDY

Railway Pension Investments Ltd lifted its holdings in shares of GoDaddy Inc. (NYSE:GDDY - Free Report) by 112.0% in the third quarter, according to the company in its most recent disclosure with the...

Stanley Laman Group Ltd. Invests $3.71 Million in GoDaddy Inc. $GDDY

Stanley Laman Group Ltd. bought a new position in shares of GoDaddy Inc. (NYSE:GDDY - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...

GoDaddy is Now Oversold (GDDY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

GoDaddy (NYSE:GDDY) Hits New 12-Month Low - Should You Sell?

GoDaddy (NYSE:GDDY) Sets New 52-Week Low - Here's Why...

Ethic Inc. Has $2.92 Million Stock Position in GoDaddy Inc. $GDDY

Ethic Inc. lessened its position in shares of GoDaddy Inc. (NYSE:GDDY - Free Report) by 29.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission...

VIRGINIA RETIREMENT SYSTEMS ET Al Has $51.52 Million Stock Holdings in GoDaddy Inc. $GDDY

VIRGINIA RETIREMENT SYSTEMS ET Al trimmed its holdings in shares of GoDaddy Inc. (NYSE:GDDY - Free Report) by 16.5% in the third quarter, according to the company in its most recent filing with the...

Boston Trust Walden Corp Takes Position in GoDaddy Inc. $GDDY

Boston Trust Walden Corp acquired a new position in GoDaddy Inc. (NYSE:GDDY - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund...

GoDaddy, Inc. engages in the provision of simple and easy-to-use products on a single technology platform wrapped with personalized guidance. It operates under the Applications and Commerce (A and C) and Core Platform (Core) segments. The A and C segment includes selling products containing proprietary software, commerce products, third-party email, productivity solutions, and certain products included in bundled offerings of proprietary software products. The Core segment includes domain registrations and renewals, aftermarket domain sales, website hosting products, website security products not included in bundled offerings of proprietary software, and products that do not contain a software component. The company was founded by Robert R. Parsons in 1997 and is headquartered in Tempe, AZ.

Godaddy Inc - Ordinary Shares - Class A

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$113.54
Prev Close	$115.60
Open	$115.11
Dividend Yield	0.00%
50-Day Moving Average	$127.08
Beta	0.84
Avg. Volume	1.39M
PE Ratio	19.92

52-Week High	$216.00
52-Week Low	$114.36
Market Capitalization	$15.62B
EPS (Annual)	$6.45
Price to Book	170.60
Revenue Per Employee	$828,071.77
Enterprise Value/EBITDA	N/A

GDDY
Godaddy Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GDDY News

GDDYGodaddy Inc - Ordinary Shares - Class A